GLP-1 Drugs for Longevity — The Complete Guide to Tirzepatide vs Semaglutide (2026)

GLP-1 receptor agonists have revolutionized metabolic medicine. But behind the weight-loss headlines, researchers are uncovering systemic anti-inflammatory, cardioprotective, and neuroprotective properties. In this video, we compare single-action Semaglutide (Ozempic/Wegovy) against dual-action Tirzepatide (Mounjaro/Zepbound) head-to-head for longevity, explain the severe risk of muscle loss, and reveal the 3 rules to protect your physical healthspan. ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ ⏱️ TIMESTAMPS: 0:00 — Introduction & Sarcopenia Warning 1:15 — What Is Natural GLP-1? 2:30 — Semaglutide: Ozempic & Wegovy Science 3:45 — The Landmark SELECT Cardiovascular Trial 4:30 — Tirzepatide: Mounjaro & Zepbound "Twincretin" 5:45 — SURMOUNT Trial 20%+ Weight Loss Results 6:30 — Systemic Inflammation & Neuroprotection 7:30 — The Sarcopenia Trap (40% Muscle Loss) 8:45 — 3 Non-Negotiable Muscle Protection Rules 9:45 — GI Side Effects & Thyroid Black-Box Warning 10:30 — Micro-Dosing Maintenance & Weight Rebound ━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━ ⚠️ DISCLAIMER: This video is for educational purposes only. GLP-1 medications are potent prescription pharmaceuticals requiring strict medical oversight. Never obtain unverified compounded GLP-1s online. Always consult a licensed physician and monitor body composition via DEXA scans.